Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CERS · against 1,335 other Healthcare companies
Ranked #876 of 1,336 · scores higher than 34% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 30–39, including CERS · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | CERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -2.5% | 4.7% | 32% | 33% | |
| Operating marginHigher is better · 1,251 reported | -0.6% | 7.1% | 32% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -3.3% | 1.7% | 33% | 33% | |
| Return on equityHigher is better · 1,252 reported | -10.8% | 3.2% | 31% | Context only | |
| Gross marginHigher is better · 1,394 reported | 52.0% | 45.9% | 56% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 876 | 3.2B CNY (≈$443M) | 34 | 27 | |
| 876 | 6.9B CNY (≈$967M) | 34 | 26 | |
| 876 | 1.9B CNY (≈$264M) | 34 | 27 | |
| 876 | 148M AUD (≈$98M) | 34 | 39 | |
| 876 | 472M USD | 34 | 33 | |
| 876 | 987M CHF (≈$1.1B) | 34 | 42 | |
| 876 | 1.5B USD | 34 | 43 | |
| 876 | 366M CHF (≈$421M) | 34 | 23 | |
| 876 | 20.5B INR (≈$246M) | 34 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score